○Katsunori Sasahara 1,2, Akira Mashima 1, Tatsusada Yoshida 1, Hiroshi Chuman 1 (1.Institute of Biomedical Sciences, Tokushima University Graduate School, 2.Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.)
Session information
Oral Presentation
5.Phase I enzyme・Regulation
Fri. Nov 13, 2015 4:00 PM - 5:10 PM Room F (2F Hourai)
Chair:Teruko Imai (Faculty of Pharmaceutical Sciences, Kumamoto University), Masahiro Hiratsuka (Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University), Kiyoshi Nagata (Department of Environmental and Health Science Tohoku Pharmaceutical University), Takeo Nakanishi (Faculty of Pharmaceutical Sciences, Kanazawa University)
○Tatsuki Fukami , Takaya Kurokawa , Tomohiro Yoshida , Miki Nakajima (Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University)
○Hiroshi Arakawa 1, Hiroki Kamioka 1, Yoko Idota 1, Kentaro Yano 1, Takuo Ogihara 2 (1.Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare, 2.Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare)
○Jun Terashima 1, Shinpei Goto 2, Hiroki Hattori 1, Sawaka Hoshi 1, Kenzo Kudo 2, Wataru Habano 1, Shogo Ozawa 1 (1.School of Pharmacy, Iwate Medical University, 2.Department of Pharmacy, Iwate Medical University Hospital)
○Han Vit Yu , Youngjoo Kwon (College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University)
○Yang Hyun Ok (Natural Products Research Center, Korea Institute of Science and Technology)